Kevin Hrusovsky

Founder & Chair @PPHSUMMIT. Chairman & CEO @QuanterixSimoa.
#PrecisionHealth Pioneer, #Biotech Entrepreneur, Author, Healthspan Visionary Transforming Medicine

[Kevin Hrusovsky @KevinHrusovsky]

Thrilled to announce that @QuanterixSimoa is partnering with and received funding from @TheADDF to accelerate the development of a #multianalyte plasma test for #Alzheimers. Learn more about the advancements we hope to spearhead with ADDF & @AmsterdamUMC: https://t.co/yHIMNQviWh

[Kevin Hrusovsky @KevinHrusovsky]

A new @ScienceMagazine study has revealed the critical role NfL plays in #MS research! Thanks to @QuanterixSimoa’s ability to measure NfL at ultra-low levels, researchers found that Epstein-Barr virus greatly increased the risk of subsequent MS: https://t.co/ByCFsxJrl0

[Kevin Hrusovsky @KevinHrusovsky]

#ICYMI: At #JPM22 yesterday, we discussed how Quanterix is disrupting #proteomics, particularly in #neuro and #Alzheimers research. Excited to see the breakthroughs discovered and advances in diagnostics made through the support of #Simoa and @PPHSUMMIT! https://t.co/TR3MEfVZDg

[Kevin Hrusovsky @KevinHrusovsky]

As always, great conversation with @bloombergbaybiz this week on @QuanterixSimoa’ 2021 milestones! Thanks for the opportunity, @AnneMostue.

[Kevin Hrusovsky @KevinHrusovsky]

Had a great time presenting on @QuanterixSimoa’s 2021 achievements at the @jpmorgan Healthcare Conference this morning! Exciting developments ahead: https://t.co/yVYfXTRldn #JPM22

[Kevin Hrusovsky @KevinHrusovsky]

Through @QuanterixSimoa and @PPHSUMMIT, the goal is to revolutionize the way #healthcare is provided, from reactive sick care to truly preventative healthcare. Had a great opportunity to share this vision with @BostonGlobe: https://t.co/zWPBrhglR0 #precisionhealth

[Kevin Hrusovsky @KevinHrusovsky]

Congratulations to David Walt on being awarded the prestigious @NorthwesternU Kabiller Prize! David is a #precisionhealth pioneer whose contributions to modern medicine – including Simoa – have revolutionized how we detect and treat #cancer and disease! https://t.co/UsL8qOWhmT

[Kevin Hrusovsky @KevinHrusovsky]

A new #cancer drug gets #FDA ✅: Patients with early-stage HR+ and HER2- early #breastcancer could have a new standard of care, with #Verzenio now approved. An incredible advancement that will help countless patients in their fight. https://t.co/pA6zTYnv9Y

[Kevin Hrusovsky @KevinHrusovsky]

Congratulations, @luba_greenwood. This is terrific news and huge for women in #biotech – a woman CEO with an all-woman C-suite!

[Kevin Hrusovsky @KevinHrusovsky]

The @US_FDA's Breakthrough Device designation for the Simoa pTau-181 #bloodtest marks yet another important milestone in our Powering #PrecisionHealth journey. As an aid in diagnosing #Alzheimers, we're closer to our goal of using #biomarkers to #EndAlz! https://t.co/j1s91JvRC4

[Quanterix @QuanterixSimoa]

Join @KevinHrusovsky on September 16th as he discusses how Emory University implemented COVID-19 testing for their students, faculty, and staff with Dr. John D. Roback, Professor in the Department of Pathology and Laboratory Medicine. Register: https://t.co/4Jkgb2kdV1

[Kevin Hrusovsky @KevinHrusovsky]

I’ll be chatting with @NicholasAshton on his work with some special biomarkers!

[Quanterix @QuanterixSimoa]

There is still time to register for the Biomarkers for #Alzheimer’s Disease Summit happening August 24-26! We are proud to sponsor this event with a virtual booth and a presentation on recent advances in blood-based #biomarkers for AD. More info: https://t.co/TzUP2NHvVB

[Kevin Hrusovsky @KevinHrusovsky]

👏👏

[Dr. Tom Frieden @DrTomFrieden]

The 2003 SARS outbreak led to substantial work on mRNA technology and coronavirus vaccines. We may not have this type of head start the next time a dangerous microbe emerges unless we make vaccine research and development a priority.

[Kevin Hrusovsky @KevinHrusovsky]

@1capplegate Thank you for sharing! Encourage your doctor to check your Nf-L levels! Biomarkers could unlock a lot of information for you. Good luck!

[Mike Biselli @mikebiselli]

Interesting food for thought for those of us in #healthcare. MLB veteran Theo Epstein at #HIMSS21 drew a parallel between baseball and analytics, teamwork and culture. Awesome read! https://t.co/S9HLKrlBC8

[Kevin Hrusovsky @KevinHrusovsky]

Love this countdown and this research! What was your favorite abstract or preso from #AAIC21 ?

[Quanterix @QuanterixSimoa]

Simoa technology continues to facilitate key #ALZ disease research, as evidenced by more than 80 abstracts based on Simoa technology presented at #AAIC2021. Check out our picks for the top 5 abstracts from AAIC 2021. https://t.co/v7zlRdV9Hv

[Kevin Hrusovsky @KevinHrusovsky]

Outstanding work shown at #AACI21. The Quanterix team will remain focused on bringing key #biomarkers to these researchers as we pioneer a new field of ‘neuro diagnostic therapies’ to improve outcomes for those suffering from diseases like #Alzheimers! https://t.co/cKiyOPNeE9

[908 Devices @908Devices]

Excited to announce the appointment of six new individuals to our Scientific Advisory Board! Please join us in welcoming Ileana Cristea, @1jvaneyk, Anne-Claude Gingras, Jesper Olsen, @RenASRobinson1, and @JohnRYatesIII. Read more details here: https://t.co/0aKdtadGb1

[Dr. Rany Aburashed @RanyAburashed]

Please join me now on @ms_cme for my accredited tweetorial launching TODAY on MRI and #biomarkers in the diagnosis of #multiplesclerosis. Free CE/#CME!! Follow us, @SFHunterMDPhD @DrJNicholas @AaronBosterMD @Brandon_Beaber @EmilyPharrMD @dr_niall @StaceyLClardy

[Kevin Hrusovsky @KevinHrusovsky]

Great to see Simoa blood based biomarkers tracking with amyloid PET and the significant impact on plaque reduction of Donanemab! #AAIC21